Temporal changes in the pathologic assessment of prostate cancer

Area of Science:

• Urology
• Pathology
• Oncology

Background:

• Prostate cancer diagnosis and management have undergone significant evolution over the past three decades.
• Prostate-specific antigen (PSA) screening has led to the detection of smaller, clinically localized tumors, often characterized by multifocality and heterogeneity.

Purpose of the Study:

• To review trends in Gleason grading and advances in pathological risk assessment for prostate cancer.
• To emphasize recent modifications in Gleason grading by the International Society of Urologic Pathology.
• To highlight the need for improved diagnostic techniques for optimal management decisions.

Main Methods:

• Review of trends in Gleason grading practices among genitourinary pathologists.
• Analysis of changes in biopsy tissue evaluation and available diagnostic tools.
• Emphasis on recent Gleason grading modifications from the International Society of Urologic Pathology.

Main Results:

• Pathologic evaluation of needle biopsy tissue remains the gold standard for prostate cancer diagnosis and risk assessment.
• Shifts in grading practices have occurred due to accumulated experience and evolving diagnostic capabilities.
• Recent Gleason grading modifications by the International Society of Urologic Pathology represent key advances.

Conclusions:

• Maximizing information from pathological specimens (morphometric, histochemical, molecular) may enhance the predictive accuracy of prostate biopsies.
• Continued development of new diagnostic techniques is crucial for optimizing prostate cancer management decisions.